Follow the GoHealth, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, GoHealth, Inc. has logged 112 reports. Market capitalisation: €8.9m. The latest transaction was disclosed on 17 August 2026 (Disposition). Among the most active insiders: CCP III Cayman GP Ltd.. Every trade is accessible without an account.
Analysts rate GoHealth, Inc. Buy (bullish), based on 3 analysts. Average price target: US$5.17.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
25 of 112 declarations
GoHealth, Inc. (ticker: GOCO) is a U.S.-listed company trading on the NASDAQ in the United States. For international investors, GoHealth is best understood as a healthcare distribution and insurance marketplace platform with a strong Medicare focus. The company was founded in 2001 by Clint Jones and Brandon Cruz, initially as a comparison site for insurance carriers. Over time, it expanded into lead generation, enrollment, and consumer matching capabilities, evolving into an integrated digital insurance marketplace. GoHealth’s corporate headquarters are in Chicago, Illinois. The company’s core business centers on a proprietary technology platform that combines machine-learning algorithms, more than two decades of insurance purchasing behavior, and licensed human agents. This hybrid model is designed to help consumers find health plans that fit their individual needs, particularly within Medicare. GoHealth positions itself as a consumer-first marketplace, emphasizing plan suitability, enrollment quality, and renewal economics rather than a purely transactional sales model. Historically, the company was also active in Affordable Care Act enrollment, but its strategic center of gravity has shifted toward Medicare in recent years. From a competitive standpoint, GoHealth operates in a fragmented but highly competitive environment that includes insurance brokers, digital enrollment platforms, lead-generation businesses, and insurers with their own distribution channels. Its relative advantage lies in the combination of proprietary technology, licensed sales support, and the ability to process large enrollment volumes. Management continues to focus on improving conversion efficiency, strengthening back-book economics, and refining consumer matching. The company does not pay dividends and instead reinvests in its technology stack, licensed agent force, and the Encompass platform. Recent developments suggest a company in strategic transition. In its latest disclosures and earnings communications, GoHealth has emphasized cash discipline, portfolio durability, and a more selective stance on Medicare Advantage, while maintaining leadership in Special Needs Plans (SNP). A notable strategic step was the 2025 launch of GoHealth Protect, an expansion beyond Medicare-related products into life insurance designed to address end-of-life and broader financial protection needs. The company is also investing in AI and operational efficiency, while management has indicated that consolidation opportunities remain part of its long-term strategic framework in a still-fragmented industry.